Patient Education
Share your love
Oculis Finalizes Phase 2 Trial Enrollment for OCS-05 in AON
Oculis has completed enrollment in its multicenter, randomized, double-blind, placebo-controlled phase 2 ACUITY trial evaluating the safety and tolerability of OCS-05 in patients with Acute Optic Neuritis (AON). Topline results are expected in Q4 2024. The phase 2 ACUITY study…
Contact Lens with Lubricant Bacteria Combats Dry Eye
Researchers have developed a new type of contact lens that contains a community of lubricant-producing bacteria to combat contact lens-associated dry eye, a common issue that leads many to discontinue use. The findings were published in Advanced Materials. Innovative Solution…
3D Retinal Electrodes to Restore Vision in the Blind
A groundbreaking study led by Professor Sohee Kim from the Department of Robotics and Mechatronics Engineering at the Daegu Gyeongbuk Institute of Science & Technology has led to the development of three-dimensional retinal electrodes. These electrodes, designed to resemble convex…
Smart Contact Lenses for Blood Glucose Monitoring
Researchers at Yonsei University, along with their counterparts from other leading institutions, announced a significant breakthrough in diabetes management with the development of smart contact lenses. These lenses are capable of analyzing components in tears to monitor blood glucose levels…
UV Radiation at Outdoor Events Linked to Photokeratitis
In a recent publication in JAMA Ophthalmology, researchers have highlighted the potential dangers of ultraviolet (UV) radiation during outdoor recreational activities, particularly pointing to its association with photokeratitis. The study, led by Julia Y.Y. Chan, M.B.B.S., from the Chinese University…
Staar Surgical and IQ Laser Vision Expand EVO ICL Use in the US
Staar Surgical announced a strategic partnership with IQ Laser Vision, a prominent vision correction organization with locations throughout California and Texas. This collaboration aims to significantly increase the use of EVO ICL lenses for surgical vision correction, specifically targeting patients…
AsclepiX Completes Enrollment in DISCOVER Trial for Wet AMD
AsclepiX Therapeutics has successfully completed the enrollment for the DISCOVER trial (NCT05859776), which evaluates the safety and tolerability of three different doses of AXT107 (gersizangitide) in patients with wet Age-related Macular Degeneration (AMD). Trial Design and Objectives The trial includes…
Novel Gene Therapy Improves Vision in Children with LCA
In a landmark clinical trial, CRISPR-Cas9 gene editing has proven safe and effective in treating a form of inherited blindness, marking a significant milestone in genetic medicine. The multi-site BRILLIANCE trial, involving the Perelman School of Medicine at the University…
Eye Ultrasound Effective for Child Brain Shunt Detection
Researchers have unveiled promising findings at the Pediatric Academic Societies (PAS) 2024 Meeting in Toronto, indicating that an eye ultrasound could swiftly and safely diagnose brain drainage tube failures in children at emergency departments. This innovative approach primarily targets children…
EyePoint’s Duravyu Misses Phase 2 NPDR Trial Goal
EyePoint Pharmaceuticals announced the topline results from its phase 2 PAVIA clinical trial, which evaluated the efficacy of Duravyu (vorolanib intravitreal insert), formerly known as EYP-1901, in treating non-proliferative diabetic retinopathy (NPDR). The trial revealed that Duravyu did not achieve…